PHARMACOLOGICAL SYNERGY BETWEEN HIGH-DOSE ARA-C (HIDAC) AND MITOXANTRONE (MIT) IN MURINE LEUKEMIA L5178Y

被引:0
|
作者
WANG, LM [1 ]
CAPIZZI, RL [1 ]
CONTENTO, M [1 ]
DIMLING, J [1 ]
机构
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,ONCOL RES CTR,WINSTON SALEM,NC 27103
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:376 / 376
页数:1
相关论文
共 50 条
  • [31] Treatment of acute myeloid leukemia (AML) at diagnosis in 99 unselected adults with high dose ARA-C (HIDAC) and mitoxantrone: Long-term follow-up.
    Keating, A
    Gandhi, MK
    Crump, M
    Smith, A
    Belch, A
    Baker, MA
    BLOOD, 1996, 88 (10) : 833 - 833
  • [32] A Randomized Comparison of Modified Intermediate-dose Ara-C versus High-dose Ara-C in Post-remission Therapy for Acute Myeloid Leukemia
    Fukushima, Toshihiro
    Urasaki, Yoshimasa
    Yamaguchi, Masaki
    Ueda, Mikio
    Morinaga, Koji
    Haba, Toshihiro
    Sugiyama, Toshiro
    Nakao, Shinji
    Origasa, Hideki
    Umehara, Hisanori
    Ueda, Takanori
    ANTICANCER RESEARCH, 2012, 32 (02) : 643 - 647
  • [33] RELATIONSHIP OF [H-3] ARA-C INCORPORATION AND RESPONSE TO THERAPY WITH HIGH-DOSE ARA-C IN AML PATIENTS - A LEUKEMIA INTERGROUP STUDY
    RAZA, A
    GEZER, S
    ANDERSON, J
    LYKINS, J
    BENNETT, J
    BROWMAN, G
    GOLDBERG, J
    LARSON, R
    VOGLER, R
    PREISLER, HD
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (10) : 1194 - 1200
  • [34] RELATIONSHIP BETWEEN PLASMA ARA-C AND INTRACELLULAR ARA-CTP POOLS UNDER CONDITIONS OF CONTINUOUS INFUSION AND HIGH-DOSE ARA-C TREATMENT
    RUSTUM, YM
    SLOCUM, HK
    WANG, G
    BAKSHI, D
    KELLY, E
    BUSCAGLIA, D
    WRZOSEK, C
    EARLY, AP
    PREISLER, H
    MEDICAL AND PEDIATRIC ONCOLOGY, 1982, : 33 - 43
  • [35] MITOXANTRONE-INDUCED DNA DAMAGE IN LEUKEMIC-CELLS IS ENHANCED BY TREATMENT WITH HIGH-DOSE ARA-C
    HEINEMANN, V
    MURRAY, D
    ADAMS, T
    WALTERS, R
    MEYN, R
    PLUNKETT, W
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 118 - 118
  • [36] DNA SINGLE-STRAND BREAKAGE (SSB) BY HIGH-DOSE ARA-C (HIDAC) ALONE AND IN COMBINATION WITH ARA-U OR VP-16
    WANG, LM
    CONTENTO, M
    CAPIZZI, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 244 - 244
  • [37] DOSE-RELATED PHARMACOLOGICAL EFFECTS OF HIGH-DOSE ARA-C AND ITS USE IN COMBINATION WITH ASPARAGINASE FOR THE TREATMENT OF PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
    CAPIZZI, RL
    POWELL, BL
    COOPER, MR
    RATHMELL, JP
    WHITE, JC
    MUSS, HB
    RICHARDS, F
    JACKSON, DV
    STUART, JJ
    WHITE, DR
    ZEKAN, PJ
    CRUZ, JM
    SPURR, CL
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 36 : 17 - 39
  • [38] DRUG SENSITIVITY TEST FOR PATIENTS WITH ACUTE-LEUKEMIA ON HIGH-DOSE ARA-C THERAPY
    MOMPARLER, RL
    ONETTO, N
    MOMPARLER, LF
    GYGER, M
    LECLERC, JM
    RIVARD, GE
    SEMINARS IN ONCOLOGY, 1985, 12 (02) : 31 - 33
  • [39] TREATMENT OF POOR RISK ACUTE-LEUKEMIA WITH SEQUENTIAL HIGH-DOSE ARA-C AND ASPARAGINASE
    CAPIZZI, RL
    POOLE, M
    COOPER, MR
    RICHARDS, F
    STUART, JJ
    JACKSON, DV
    WHITE, DR
    SPURR, CL
    HOPKINS, JO
    MUSS, HB
    RUDNICK, SA
    WELLS, R
    GABRIEL, D
    ROSS, D
    BLOOD, 1984, 63 (03) : 694 - 700
  • [40] SUBACUTE PULMONARY FAILURE COMPLICATING THERAPY WITH HIGH-DOSE ARA-C IN ACUTE-LEUKEMIA
    ANDERSSON, BS
    COGAN, BM
    KEATING, MJ
    ESTEY, EH
    MCCREDIE, KB
    FREIREICH, EJ
    CANCER, 1985, 56 (09) : 2181 - 2184